Israel Englander Novo Cure LTD Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Novo Cure LTD stock. As of the latest transaction made, Millennium Management LLC holds 735,227 shares of NVCR stock, worth $14.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

735,227

Previous 300,000 145.08%

Holding current value

$14.1 Million

Previous $4.69 Million 367.24%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$14.54 - $33.41 $6.75 Million - $15.5 Million	464,416 Added 171.49%	735,227 $21.9 Million
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $14.6 Million - $21.8 Million	-935,081 Reduced 77.54%	270,811 $4.23 Million
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $206,670 - $420,153	-17,470 Reduced 1.43%	1,205,892 $20.7 Million
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $2.04 Million - $2.84 Million	164,222 Added 15.51%	1,223,362 $19.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $11.3 Million - $16 Million	1,014,324 Added 2263.31%	1,059,140 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $1.14 Million - $2.33 Million	28,265 Added 170.78%	44,816 $1.86 Million
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $934,138 - $1.97 Million	16,551 New	16,551 $995,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $5.43 Million - $7.16 Million	-79,897 Reduced 95.53%	3,738 $284,000
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $4.57 Million - $7.26 Million	80,778 Added 2827.37%	83,635 $5.81 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $7.63 Million - $10.7 Million	-126,841 Reduced 97.8%	2,857 $237,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $9.5 Million - $15.4 Million	126,574 Added 4051.66%	129,698 $9.74 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $934,355 - $1.56 Million	-8,043 Reduced 72.02%	3,124 $363,000
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $13.5 Million - $23.4 Million	-103,541 Reduced 90.26%	11,167 $2.48 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $8.44 Million - $13.1 Million	75,265 Added 190.82%	114,708 $19.8 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $13.3 Million - $25.5 Million	-229,536 Reduced 85.34%	39,443 $4.39 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $15.1 Million - $19.7 Million	264,373 Added 5739.75%	268,979 $16 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $262,772 - $441,024	4,606 New	4,606 $310,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $1.48 Million - $2.04 Million	-21,697 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $2.4 Million - $3.79 Million	-38,718 Reduced 64.09%	21,697 $1.62 Million
Q2 2019 Aug 14, 2019	SELL	$42.22 - $63.23 $2.54 Million - $3.81 Million	-60,212 Reduced 49.92%	60,415 $3.82 Million
Q1 2019 May 14, 2019	BUY	$31.96 - $56.12 $3.86 Million - $6.77 Million	120,627 New	120,627 $5.81 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $363,911 - $666,874	-12,671 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $4.51 Million - $7.38 Million	-140,794 Reduced 91.74%	12,671 $664,000
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $1.87 Million - $3.01 Million	-93,959 Reduced 37.97%	153,465 $4.8 Million
Q1 2018 May 15, 2018	SELL	$19.3 - $23.65 $4.58 Million - $5.61 Million	-237,145 Reduced 48.94%	247,424 $5.39 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $1.7 Million - $2.28 Million	104,210 Added 27.4%	484,569 $9.79 Million
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $6.87 Million - $8.27 Million	380,359	380,359 $7.55 Million

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.01B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account